STI
46
-4
MMC
37
-3
FOXA
67
3
ADI
54
5
EQT
33
-4
ETR
68
5
APH
48
3
PLD
35
5
PEG
60
3
AAPL
53
5
KMI
83
2
AFL
32
2
GILD
52
-2
OI
32
-2
SYF
78
7
PAYX
38
2
ABBV
53
3
PCAR
39
5
MPC
38
5
BBY
50
-2
STI
46
-4
MMC
37
-3
FOXA
67
3
ADI
54
5
EQT
33
-4
ETR
68
5
APH
48
3
PLD
35
5
PEG
60
3
AAPL
53
5
KMI
83
2
AFL
32
2
GILD
52
-2
OI
32
-2
SYF
78
7
PAYX
38
2
ABBV
53
3
PCAR
39
5
MPC
38
5
BBY
50
-2
Financhill
Back

Nurix Therapeutics 10K Form

Sell
11

NRIX
Nurix Therapeutics

Last Price:
$19.68
Seasonality Move:
-8.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NRIX News And Ratings

See the #1 stock for the next 7 days that we like better than NRIX

NRIX Financial Statistics

Sales & Book Value

Annual Sales: $77M
Cash Flow: $-44.5M
Price / Cash Flow: 0
Annual Sales: $5.62
Price / Book: 3.7

Profitability

EPS (TTM): -2.91000
Net Income (TTM): $-177M
Gross Margin: --
Return on Equity: -65.52%
Return on Assets: -44.22%

Nurix Therapeutics Earnings Forecast

Key Nurix Therapeutics Financial Ratios

  • The Research & Development expenses have been 245.69% of Revenue.
  • The Net Earning history of NRIX is -186.98% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Nurix Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: NRIX
CUSIP: 67080M
Website: nurixtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.28
Quick Ratio: 5.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

NRIX Technical Analysis vs Fundamental Analysis

Sell
11
Nurix Therapeutics (NRIX) is a Sell

Is Nurix Therapeutics a Buy or a Sell?